Mode
Text Size
Log in / Sign up
N/A N=445

Platelet Count Trends in Pre-eclamptic Parturients

Obstetric Labor Complications · Preeclampsia · Thrombocytopenia

Enrolled (actual)
445
Serious AEs
0.0%
Results posted
Feb 2012
Primary outcome: Primary: Positive Predictive Value of Earliest Available Platelet Count — 99; 90; 100 percentage of positive platelet counts

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Age
Adult · 18+ yrs
Sex
Female
Sponsor
Northwestern University
Primary completion
May 2003

Outcome Measures

OutcomeResultp-value
PRIMARY
Positive Predictive Value of Earliest Available Platelet Count
99; 90; 100
SECONDARY
Positive Predictive Value of Platelet Count Closet to Neuraxial Analgesia
99; 93; 100
SECONDARY
Time Interval (Hours) From Closet Platelet Count to Initiation of Neuraxial Analgesia
4; 3; 4

Summary

Thrombocytopenia (platelet count < 100,000/mL) occurs in approximately 15% of women with preeclampsia. Neuraxial analgesia is contraindicated in parturients with a coagulopathy; therefore, the platelet count(PC) is routinely checked prior to the initiation of neuraxial analgesia in women with preeclampsia/eclampsia. Catheter removal is also contraindicated in the presence of a coagulopathy. Some women have an acceptable PC at the initiation of neuraxial analgesia, but may become significantly more thrombocytopenic during labor and delivery. In a study of severely preeclamptic parturients, some with HELLP (H=hemolysis of red blood cells, EL=elevated liver enzymes, LP=low platelet count) syndrome, the admission PC correlated with the PC nadir. However, the natural progression of the PC has not been studied in women with mild preeclampsia. We hypothesize that women with mild preeclampsia or severe preeclampsia without HELLP syndrome, and whose admission PC is greater than 150,000/mL, will have a stable PC during the course of labor and delivery and do not require another PC check prior to initiation of neuraxial analgesia or removal of the epidural catheter. The purpose of this study is to determine the positive predictive value of an initial PC greater than 150,000/mL for maintaining a PC greater than 80,000/mL during labor and delivery.

Eligibility Criteria

Inclusion Criteria

  • All participants who delivered between January 1, 2000 and December 31, 2002, identified as having preeclampsia (without HELLP syndrome) in the Perinatal Database.

Exclusion Criteria

  • Participants not diagnosed with preeclampsia and/or outside the given criteria dates.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00787241). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search